Summary
Jacob DeWitte, Co-Founder and Chief Executive Officer of Oklo Inc. (NASDAQ: OKLO), sold a block of Class A common stock on February 2, 2026. The transactions, executed under a Rule 10b5-1 trading plan adopted March 31, 2025, totaled 192,462 shares at prices ranging from $73.8095 to $78.2003 and produced proceeds of roughly $1.49 million. Oklo has also been in the news for a binding agreement with Meta to develop a phased 1.2 GW advanced nuclear campus and for subsequent analyst activity tied to that agreement. The company did not disclose earnings or revenue results.
Insider transaction details
According to a Form 4 filed with the Securities and Exchange Commission, DeWitte disposed of 192,462 shares of Oklo Class A Common Stock on February 2, 2026. The sale prices for those shares ranged between $73.8095 and $78.2003, and the total amount realized was approximately $1.49 million. The sale was carried out pursuant to a Rule 10b5-1 trading plan that DeWitte adopted on March 31, 2025.
Post-transaction holdings
Following the dispositions, DeWitte still directly holds 748,197 shares. Indirect holdings attributed to him include 1,350,000 shares held through Jacob DeWitte GRAT, 7,851,901 shares held by the Jacob DeWitte Family Trust, and 1,000,000 shares held by Jacob DeWitte GRAT No. 2.
Related parties also retain significant positions. Caroline Cochran is listed as indirectly holding 739,023 shares. Additional indirect holdings tied to her include 1,350,000 shares via Caroline Cochran GRAT, 7,583,085 shares held by the Caroline DeWitte Family Trust, and 1,000,000 shares held by Caroline DeWitte GRAT No. 2.
Corporate developments and analyst reactions
Oklo recently secured a binding agreement with Meta to develop a phased 1.2 GW advanced nuclear campus. That arrangement includes customer prepayments for early development work under the terms described in company disclosures.
The Meta agreement has prompted shifts in analyst coverage. BofA Securities upgraded Oklo from Neutral to Buy and raised its price target from $111.00 to $127.00. Wedbush reiterated an Outperform rating and assigned a $150.00 price target, highlighting Oklo’s role in Meta’s plans for up to 6.6 gigawatts of new nuclear energy projects. Texas Capital Securities initiated coverage with a Buy rating and a $138.00 price target, citing Oklo’s advanced nuclear solutions and its Aurora reactor technology. UBS maintained a Neutral rating with a $95.00 price target following the Meta deal.
Key points
- Jacob DeWitte sold 192,462 shares of Oklo Class A common stock on February 2, 2026, totaling roughly $1.49 million in proceeds.
- The sales were conducted pursuant to a Rule 10b5-1 trading plan adopted March 31, 2025, and DeWitte retains substantial direct and indirect holdings in the company.
- Oklo signed a binding agreement with Meta to develop a phased 1.2 GW advanced nuclear campus, prompting multiple analyst rating actions and price target changes.
Risks and uncertainties
- Earnings and revenue results for Oklo were not disclosed in the materials referenced, leaving financial performance unspecified.
- Analyst ratings and price targets vary significantly, reflecting differing assessments of Oklo’s prospects and the commercial implications of the Meta agreement.
- The information provided does not detail the full terms of the Meta arrangement beyond mention of customer prepayments and the phased 1.2 GW project, limiting visibility into project economics and timelines.
What this means for markets and sectors
The combination of insider selling activity and large commercial progress with a major technology customer has drawn attention to Oklo’s position in the advanced nuclear energy sector. The developments touch energy markets, nuclear technology investors, and equity markets tracking companies with strategic partnerships.
Bottom line
DeWitte’s February 2, 2026 sales were executed under a pre-established 10b5-1 plan and generated approximately $1.49 million. Oklo’s business narrative concurrently includes a binding commitment with Meta to develop a phased 1.2 GW nuclear campus, which has been followed by divergent analyst ratings and price targets. The company’s earnings and revenue figures were not disclosed in the referenced filings.